Is a complete GUTS research report available?

No complete published report is available for Fractyl Health, Inc. (GUTS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Fractyl Health, Inc. (GUTS)

NASDAQ: GUTS · USD

$0.69

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GUTS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	109.5M
Net income (ttm)	-108M
EPS (ttm)	-$1.05
Shares out	158.6M
Volume	738,095
Beta	2.29
Price target	$5.03	+629.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -108M
EPS (ttm): -$1.05
Market cap: 109.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GUTS indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001572616
Company name	Fractyl Health, Inc.
Country	United States
Country code	US
Cusip	35168W103
Employees	100
Employees Change	-7%
Employees Change Percent	-6.54
Enterprise value	$109.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-02-02
Isin	US35168W1036
Last refreshed	2026-07-31
Market cap	$109.5M
Market cap category	Micro-Cap
Price	$0.69
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	3841
Symbol	GUTS
Website	https://fractyl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-96.9%
FCF yield	-78.81%
P/B ratio	5.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-108M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
Profitable Quarters	$1
ROA	-63.64
Roa5y	-46.78
ROCE	-110.6
ROE	-778.3
ROIC	-77.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-62.11%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$99.4M
Cash	$63.2M
Current Assets	$65.9M
Current Liabilities	$15.4M
Debt	$60.8M
Debt Equity	$2.84
Equity	$21.4M
Liabilities	$78M
Long Term Assets	$33.5M
Long Term Liabilities	$62.6M
Net Cash	$2.4M
Net Cash By Market Cap	$2.11
Net Debt Equity	$-0.11
Tangible Book Value	$21.4M
Tangible Book Value Per Share	$0.13
WACC	10.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.28
Net Working Capital	$-7.5M
Quick ratio	4.1
Working Capital	$50.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-113.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-62.09%
200-day SMA	1.04
50-day SMA	0.8
50-day SMA vs 200-day SMA	50under200
All Time High	14.5
All Time High Change	-95.24%
All Time High Date	2024-02-02
All Time Low	0.38
All Time Low Change	82.93%
All Time Low Date	2026-02-05
ATR	0.06
Beta	2.29
Beta1y	1.45
Beta2y	1.39
Ch YTD	-68.64
High	0.72
High52	2.45
High52 Date	2025-12-12
High52ch	-71.78%
Low	0.69
Low52	0.38
Low52 Date	2026-02-05
Low52ch	82.93%
Ma50ch	-13.25%
Premarket Change Percent	2.17
Premarket Price	$0.71
Premarket Volume	7,667
Price vs 200-day SMA	-33.72%
RSI	40.04
RSI Monthly	27.49
RSI Weekly	43.27
Sharpe ratio	-0x
Sortino ratio	0.04
Total Return	-113.62%
Tr YTD	-68.64
Tr1m	-13.27%
Tr1w	-8.81%
Tr3m	14.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	4
Analyst Price Target Top	$5.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.14
Operating Income	$-92.9M
Price target	$5.03
Price Target Change	$629
Price Target Change Top	$697

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	143,266,020%
Float Percent	90.3%
Net Borrowing	-471,000
Shares Insiders	1.27%
Shares Institutions	46.72%
Shares Out	158,648,963
Shares Qo Q	12.77%
Shares Yo Y	113.62%
Short Float	1.76%
Short Ratio	1.37
Short Shares	1.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-95.6M
Adjusted OCF	-95,535,000
Average Volume	2,002,321.65x
Bv Per Share	0.13
CAPEX	$-109,000
Ch1m	-13.27
Ch1w	-8.81
Ch1y	-62.09
Ch3m	14.62
Ch6m	17.97
Change	0%
Change From Open	-2.13
Close	0.69
Days Gap	2.17
Depreciation Amortization	1,120,000
Dollar Volume	509,285.6
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-92.9M
EBITDA	$-91.8M
EPS	$-1.05
F Score	2
FCF	$-87.8M
FCF EV Yield	-80.51x
FCF Per Share	$-0.55
Financing CF	108,895,000
Fiscal Year End	December
Founded	2,010
Investing CF	-109,000
Ipr	-95.32
Iprfo	-94.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-24
Ma150	0.87
Ma150ch	-20.61%
Ma20	0.78
Ma20ch	-11.48%
Net CF	21,060,000
Next Earnings Date	2026-08-11
Open	0.71
Optionable	No
Position In Range	0
Post Close	0.69
Postmarket Change Percent	0.57
Postmarket Price	$0.69
Ppne	28,529,000
Pre Close	0.69
Price Date	2026-07-30
Ptbv Ratio	5.21
Relative Volume	0.37x
Share Based Comp	7,809,000
Tr6m	17.97%
Us State	Massachusetts
Volume	738,095

Fractyl Health, Inc. (GUTS)

Coverage state: Market snapshot only — no published research

Generate the first GUTS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GUTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GUTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GUTS

Frequently asked questions